quinlash wrote: It's all about the ratios.
For Zenabis HEXO issued 17,600,000 shares
For 48-North HEXO is expecting to issue 5,600,000 shares
For Redecan HEXO is expecting to issue 69,700,000 shares
When you combine that total number of shares with the projected incremental increase in sales the price paid for shares at the current shareprice the ratio takes a dive. In this case a dive is a beautiful thing. If you think the new resulting total share count is high then you can compare the sharecount to any of the other producers you consider as comparible to HEXO.
Frankly.. if you don't do the research and don't have the stomach for price swings you are either not cut out for the Cannabis sector or you are just not cut out for the StockMarket in any capacity.
If you do the work, and you are confident in your trades, you will win... given time.
GLTA
Q
quinlash wrote: Most current top-line / gross sales from HEXO: $33,028,000 (CDN)
Most current top-line / gross sales from Zenabis $16,179,000 (CDN)
Most current top-line / gross sales from 48-North $5,200,000 (CDN)
Most current top-line / gross sales from Redecan $58,000,000 (CDN)
Combined projected top-line sales figure $ $112,407,000 (CDN)
x4 for annual = $449,628,000
Here is what you can to do get to know each of company's better and to execise your hidden super power of thinking and researching on your own... go find the NET Sales figures. You can also check to see if the net number has been increasing QTR over QTR... here's the great part of that.. IT'S YOUR RESEARCH and you're not counting on a Stock Forum to confirm what you really need to know !
GLTA
Long on HEXO and happy to .... Do My Own Research !!
Q